Glycolipids as potential binding sites for HIV: Topology in the sperm plasma membrane in relation to the regulation of membrane fusion

Journal of Reproductive Immunology

Volumn 41, Issue 1-2, 1998, Pages 233-253

  Gadella, B M ^a   HamMacHe, D ^b   Pieroni G ^c   Colenbrander, B ^a   Van Golde, L M G ^a   Fantini, J ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

Adhesion; AIDS; Fusion; Gp120; Sperm glycolipids

Indexed keywords

ACYLGLYCEROL; CD4 ANTIGEN; GALACTOSYLCERAMIDE; GLYCOLIPID; GLYCOPROTEIN GP 120; RECEPTOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL TISSUE; BINDING SITE; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUALLY TRANSMITTED DISEASE; SPERM; SWINE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

CELL MEMBRANE; GLYCOLIPIDS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MALE; MEMBRANE FUSION; RECEPTORS, HIV; SPERMATOZOA;

EID: 0032445493     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00061-8     Document Type: Conference Paper

References (57)

1. 2+-dependent secretion (acrosome reaction) in boar spermatozoa. J. Cell Sci. 93:1989;467-479.
2. Alexander N.J. Sexual transmission of human immunodeficiency virus: virus entry into male and femal genital tract. Fertil. Steril. 54:1990;157-165.
3. Arts E.G.J.M., Jager S., Hoekstra D. Evidence for the existence of lipid-diffusion barriers in the equatorial segment of human spermatozoa. Biochem. J. 304:1994;211-218.
4. Baccetti B., Benedetto A., Burrini A.G., Collodel G., Costantino-Ceccarini E., Crisa N., Di Caro A., Estenoz M., Garbuglia A.R., Massacesi A., Piomboni P., Reneiri T., Sollazzo D. HIV-1 particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J. Cell Biol. 127:1994;903-914.
5. Baccetti B., Collodel G., Piomboni P. The debate on the presence of HIV-1 virus in human spermatozoa. Drug Discov. Des. 5:1996;129-142.
6. + UT-7 megakaryotic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differntiation by HIV-1 infection. Blood. 89:1997;2670-2678.
7. Bansal R., Warrington A.E., Gard A.L., Ranscht B., Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies O1, O4 and R used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:1989;548-557.
8. Benjouad A., Chapuis F., Fenouillet E., Gluckman J.C. Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4. Virology. 206:1995;457-464.
9. Bertozzi C.R., Cook D.G., Kobertz W.R., Gonzalez-Scarano F., Bednarski M.D. Carbon-linked galactosyl analogs bind specifically to HIV-1 gp120. J. Am. Chem. Soc. 114:1992;10639-10641.
10. Bhat S., Spitalnik S.L., Gonzalez-Scarano F., Silberberg D.H. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 88:1991;7131-7134.
11. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 51:1959;4226-4233.
12. Borzy M.S., Connell R.S., Kiessling A.A. Detection of human immunodeficiency virus in cell-free seminal fluid. J. Acquired Immune Defic. Syndr. 1:1988;419-424.
13. Broder C.C., Dimitrov D.S. HIV and the 7-transmembrane domain receptors. Pathobiology. 64:1996;171-179.
14. Brogi A., Presentini, Solazzo D., Piomboni P., Costantino-Ceccarini E. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res. Hum. Retroviruses. 12:1996;483-489.
15. Cook D.G., Fantini J., Spitalnik S.L., Gonzalez-Scarano F. Binding of human immunodeficiency virus type I (HIV-I) gp120 to galactosylcermide (GalCer): relationship to the V3 loop. Virology. 201:1994;206-214.
16. Costantino-Ceccarini, E., Brogi, A., Strazza, M., Presentini, R., 1998. Characterization of an alternative sperm receptor for HIV-1. J. Reprod. Immun., in press.
17. Dalgleish A.G., Beverly P.C.L., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
18. Dayanithi G., Yahi N., Baghdiguian S., Fantini J. Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy. Cell Calcium. 18:1995;9-18.
19. De Haas C.G.M., Lopes-Cardozo M. Hydroxy- and non-hydroxy galactolipids in developing rat CNS. Int. J. Fevl. Neurosci. 13:1995;447-454.
20. Delézay O., Hammache D., Fantini J., Yahi N. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. Biochemistry. 35:1996;15663-15671.
21. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA. 90:1993;2700-2704.
22. Fantini J., Hammache D., Delézay O., Yahi N., Andre-Barres C., Rico-Lattes A. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1 induced fusion and entry. J. Biol. Chem. 272:1997;7245-7252.
23. Gadella B.M., Colenbrander B., van Golde L.M.G., Lopes-Cardozo M. Characterization of three arylsulfatases in semen: seminolipid sulfohydrolase activity is present in seminal plasma. Biochim. Biophys. Acta. 1128:1992;155-162.
24. Gadella B.M., Colenbrander B., van Golde L.M.G., Lopes-Cardozo M. Boar seminal vesicles secrete arylsulfatases into seminal plasma: evidence that desulfation of seminolipid occurs only after ejaculation. Biol. Reprod. 48:1993;483-489.
25. Gadella B.M., Gadella T.W.J. Jr., Colenbrander B., van Golde L.M.G., Lopes-Cardozo M. Visualization and quantification of glycolipid polarity dynamics in the plasma membrane of the mammalian spermatozoon. J. Cell Sci. 107:1994;2151-2163.
26. + cells in human ejaculates. Hum. Reprod. 10:1995;2923-2927.
27. Gilljam G. Envelope glycoproteins of HIV-1, HIV-2 and SIV purified with Galanthus nivalis agglutinin induce strong immune response. AIDS Res. Hum. Retroviruses. 9:1993;431-438.
28. Gobert B., Amiel C., Tang J., Barbarino P., Béné M.C., Faure G. CD4 like molecules in human sperm. FEBS Lett. 261:1990;339-342.
29. Goujet-Zalc C., Guerci A., Dubois G., Zalc B. Schwann cell marker defined by a monoclonal antibody (224-58) with specific cross reactivity. J. Neurochem. 46:1986;435-438.
30. Hammache D., Delézay O., Fantini J., Yahi N. Sumarin: a polysulfonated compound that inhibits the binding of HIV gp120 to GalCer/sulfatide and blocks the CD4-independent pathway of HIV-1 infection in mucosal epithelial cells. Perspect. Drug Discov. Des. 5:1996;225-233.
31. Hammache, D., Piéroni, G., Yahi, N., Delézay, O., Koch, N., Lafont, H., Tamalet, C., Fantini, J., 1998. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylcermide and ganglioside GM3. J. Biol. Chem. 273, 7967-7971.
32. Hansen J.E., Lund O., Nielsen J.O., Brunak S., Hansen J.E.S. Prediction of the secondary structure of HIV-1 gp120. Proteins. 25:1996;1-11.
33. 2+ influx in boar sperm populations. Mol. Reprod. Dev. 35:1993;197-208.
34. Harouse J.M., Bhat S., Spitalnik S.L., Laughlin M., Stefano K., Silberberg D.K., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253:1991;320-323.
35. Johnston D.S., Chapham D. The properties of brain galactocerebroside monolayers. Biochim. Biophys. Acta. 937:1988;10-22.
36. Kean E.L. Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. J. Lipid Res. 9:1968;319-327.
37. Klatzmann D., Champagne E., Chamaret S. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
38. Kornblatt M.J. Synthesis and turnover of sulphogalactoglycerolipid, a membrane lipid, during spermatogenesis. Can. J. Biochem. 57:1979;255-263.
39. Kundu S.K. Thin-layer chromatography of neutral glycosphingolipids and gangliosides. Method. Enzymol. 72:1981;185-204.
40. Leyton L., Saling P. 95 kDa sperm proteins bind to ZP3 and serve as a tryrosine kinase in response to zona binding. Cell. 57:1989;1123-1130.
41. Matthews T.J., Wild C., Chen C.C., Bolognesi D.P., Greenberg M.L. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:1994;93-104.
42. McAlarney T., Apostolski S., Latov N. Characteristics of HIV gp120 glycoprotein binding to glycolipids. J. Neurosci. Res. 37:1994;453-460.
43. Moore J.P., McKeating J.A., Stephens P.E., Clements G., Thomson S., Weiss R.A. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. AIDS. 4:1990;307-315.
44. Parmentier E., Monge M., Yagello M., Cabon F., Demerens C., Gluckman J.C., Zalc B. HIV-1 envelope gp120 does not bind to galactosylceramide expressing oligodendrocytes. Virology. 206:1995;1084-1091.
45. Picard L., Simmons G., Power C.A., Meyer A., Weiss R.A., Clapham P.R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71:1997;5003-5011.
46. Radin N.S. Improved version of the Kean partition assay for cerebroside sulfate. J. Lipid Res. 25:1984;651-652.
47. Sattentau Q.J., Moore J.P. Conformational changes in the human immunodeficiency virus glycoprotein by soluble CD4 binding. J. Exp. Med. 174:1991;407-412.
48. Schneider-Schaulies J., Schneider-Schaulies S., Brinkmann R., Tas P., Halbrugge M., Walter U., Holmes H.C., Ter Meulen V. HIV-1 gp120 receptor on CD4 negative brain cells activates a tyrosine kinase. Virology. 191:1992;765-772.
49. Shirley M.A., Schachter H. Enrichment of sulfogalactosylalkylacylglycerol in a plasma membrane fraction from adult testis. Can. J. Biochem. 58:1980;1230-1238.
50. Tanphaichitr N., Tayabali A., Gradil C., Jujena S., Lévéille M.C., Lingwood C.A. Role of a germ cell-specific sulfolipid-immobilizing protein (SLIP1) in mouse in vitro fertilization. Mol. Reprod. Dev. 32:1992;17-22.
51. Van den Berg L.H., Sdiq S.A., Lederman S., Latov N. The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoproetin. J. Nerol. Res. 33:1992;513-518.
52. Van der Pal R.H.M., Vos J.P., van Golde L.M.G., Lopes-Cardozo M. A rapid procedure for the preparation of of oligodendrocyte-enriched cultures from rat spinal cord. Biochim. Biophys. Acta. 1051:1990;159-165.
53. Van Genderen I.L., van Meer G., Slot J.W., Geuze H.J., Voorhout W.F. Subcellular localization of Forssman glycolipid in epithelial MDCK cells by immuno-electronmicroscopy after freeze-substitution. J. Cell Biol. 115:1991;1009-1019.
54. Van't Hof, R., van Klompenburg, W., Pilon, M., Kozubek, A., de Korkkool, G., Dernel, R., Weisbeek, P.J., de Kruÿff, B., 1993. The transit sequence mediates the specific interaction of the precursor of ferredoxin with chloroplast envelope membrane lipids. J. Biol. Chem. 268, 4037-4042.
55. Vos J.P., Lopes-Cardozo M., Gadella B.M. Metabolic and functional aspects of sulfogalactolipids. Biochim. Biophys. Acta. 1211:1994;125-149.
56. Yahi N., Baghdiguian S., Moreau H., Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66:1992;4848-4854.
57. Yahi N., Sabatier J.M., Baghdiguian S., Gonzalez-Scarano F., Fantini J. Synthetic multimeric peptides from the principal neutralization domain (V3loop) of human immunodeficiencyvirus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD-4 negative mucosal epithelial cell line. J. Virol. 69:1995;320-325.